Inventor · disambiguated record
Hao Chen
Also filed as: CHEN HAO · CHEN HAO-XUAN
25 granted patents·17 pending applications·38 citations·filing 2002–2024
92Inventor score
Files withCALIPER LIFE SCIENCES INC6CHEN HAO5JIANGSU HENGRUI MEDICINE CO5ASCENTAGE PHARMA SUZHOU CO LTD3GLOBALWAFERS CO LTD3
Top patents by PatentIndex Score
42 records- 0195US10882833B2Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereofINST MATERIA MEDICA CAMS·Filed 2017·Granted Jan 5, 2021·13 cites·22 claims
- 0285US12508741B2Ingot wafering systems and methods for slicing a silicon ingotGLOBALWAFERS CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·5 claims
- 0385US10786507B2Pharmaceutical composition containing JAK kinase inhibitor or pharmaceutically acceptable salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Sep 29, 2020·11 cites·12 claims
- 0481US9119843B2Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCHEN HAO·Filed 2010·Granted Sep 1, 2015·8 cites·8 claims
- 0579US12115699B2Ingot wafering systems and methods for slicing a silicon ingotGLOBALWAFERS CO LTD·Filed 2023·Granted Oct 15, 2024·0 cites·5 claims
- 0679US11691989B2Macrocyclic indoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jul 4, 2023·3 cites·41 claims
- 0771US12508345B2Method for preparing artificial ligament with high tensile durability, anti-fatigue, low creep and stress relaxation rate, artificial ligament prepared therefrom, and fiber collection platform by interfacial polyelectrolyte complexation spinningUNIV NAT TSING HUA·Filed 2023·Granted Dec 30, 2025·0 cites·9 claims
- 0868US9604945B2Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disordersCALIPER LIFE SCIENCES INC·Filed 2013·Granted Mar 28, 2017·1 cites·11 claims
- 0967US11752665B2Slurry sprayers, adjustable supports for same, and methods for slicing a silicon ingotGLOBALWAFERS CO LTD·Filed 2019·Granted Sep 12, 2023·0 cites·9 claims
- 1067US10654851B2Deuterated 3-(4,5-substituted aminopyrimidine)phenyl derivatives and use thereofNANJING CHUANGTE PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted May 19, 2020·1 cites·7 claims
- 1166US12318385B2Pharmaceutical composition comprising PARP inhibitorsJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Jun 3, 2025·0 cites·16 claims
- 1262US8759591B2Method for intermittently producing 4,4′-diaminodicyclohexylmethane with a low amount of the trans-trans isomerHU SHUANG·Filed 2011·Granted Jun 24, 2014·1 cites·12 claims
- 1362US2009215839A1Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disordersCHEN HAO·Filed 2009·Application pending·0 cites
- 1462US2024401082A1Treatment of Dry Age-Related Macular DegenerationGENZYME CORP·Filed 2024·Application pending·0 cites
- 1559US8080655B2Methods of making efavirenz and intermediates thereofCHEN BO·Filed 2009·Granted Dec 20, 2011·0 cites·17 claims
- 1659US2023322837A1Preparation method for and application of class of stellate bifunctional compounds targeting spike protein against respiratory tract infection virus and salt thereofSHENZHEN CELL INSPIRE PHARMACEUTICAL DEV CO LTD·Filed 2023·Application pending·0 cites
- 1759US2008319030A1Sydnonimines - specific dopamine reuptake inhibitors and their use in treating dopamine related disordersCHEN HAO·Filed 2008·Application pending·0 cites
- 1858US2025179073A1Tricyclic heterocycle compounds as iap antagonistsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 1957US8378143B2Methods of making Efavirens and intermediates thereofAPOTEX PHARMACHEM INC·Filed 2011·Granted Feb 19, 2013·0 cites·7 claims
- 2056US9149466B2Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2014·Granted Oct 6, 2015·0 cites·15 claims
- 2155US9879056B2Insecticidal proteinUNIV ZHEJIANG·Filed 2014·Granted Jan 30, 2018·0 cites·47 claims
- 2255US8415385B2Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disordersCHEN HAO·Filed 2011·Granted Apr 9, 2013·0 cites·6 claims
- 2353US2002187514A1Identification of molecular targets useful in treating substance abuse and addictionFiled 2002·Application pending·0 cites
- 2452US12415810B22'-isopropyl-spiro (3,3'-pyrrolidine oxindole) liver X receptor regulator, preparation method therefor, and use thereofSHENZHEN CELL INSPIRE PHARMACEUTICAL DEV CO LTD·Filed 2022·Granted Sep 16, 2025·0 cites·18 claims
- 2551US8691853B2Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCHEN HAO·Filed 2011·Granted Apr 8, 2014·0 cites·15 claims
- 2651US2017239224A1Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2017·Application pending·0 cites
- 2748US11576609B2Noninvasive methods for detecting liver fibrosisUNIV GEORGIA STATE RES FOUND·Filed 2018·Granted Feb 14, 2023·0 cites·20 claims
- 2847US2011020466A1Fertilized egg isolate and use thereofUNITED PARAGON ASSOCIATES INC·Filed 2009·Application pending·0 cites
- 2946US2017056379A1Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCALIPER LIFE SCIENCES INC·Filed 2016·Application pending·0 cites
- 3046US2016095839A1Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2015·Application pending·0 cites
- 3143US11498928B2Macrocyclic spiroethers as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Nov 15, 2022·0 cites·47 claims
- 3243US2023322769A1Heteroaromatic ring compound as ret kinase inhibitor, and preparation and use thereofJIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3343US2019070181A1Formulation of ticagrelor or pharmaceutically acceptable salt thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Application pending·0 cites
- 3443US2015366846A1Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCALIPER LIFE SCIENCES INC·Filed 2015·Application pending·0 cites
- 3542US11285178B2Fertilized egg isolate and uses thereofUNITED PARAGON ASS INC·Filed 2018·Granted Mar 29, 2022·0 cites·9 claims
- 3641US2023042525A1Jak kinase inhibitor pharmaceutical compositionJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 3740US10258584B2Pregabalin sustained-release preparationJIANGSU HENGRUI MEDICINE CO·Filed 2015·Granted Apr 16, 2019·0 cites·20 claims
- 3840US2004117125A1Drug discovery method and apparatusFiled 2003·Application pending·0 cites
- 3938US11674146B2Gene combination and use thereofUNIV ZHEJIANG·Filed 2016·Granted Jun 13, 2023·0 cites·24 claims
- 4036US10617649B2Preparation method of azacitidine for injectionZHEJIANG HUAHAI PHARM CO LTD·Filed 2017·Granted Apr 14, 2020·0 cites·7 claims
- 4132US2017056453A1Fertilized egg isolate and uses thereofUNITED PARAGON ASS INC·Filed 2016·Application pending·0 cites
- 4223US2012190743A1Compounds for treating disorders or diseases associated with neurokinin 2 receptor activityBAIN JERALD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hao Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →